These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22538461)

  • 21. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.
    Maseda E; Suarez-de-la-Rica A; Anillo V; Tamayo E; García-Bernedo CA; Ramasco F; Villagran MJ; Maggi G; Gimenez MJ; Aguilar L; Granizo JJ; Buño A; Gilsanz F
    J Crit Care; 2015 Jun; 30(3):537-42. PubMed ID: 25600574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.
    Wilke MH; Grube RF; Bodmann KF
    Eur J Med Res; 2011 Dec; 16(12):543-8. PubMed ID: 22112361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections.
    Li H; Luo YF; Blackwell TS; Xie CM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5900-6. PubMed ID: 21947386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procalcitonin-based algorithms to initiate or stop antibiotic therapy in critically ill patients: Is it time to rethink our strategy?
    Lam SW; Bauer SR; Duggal A
    Int J Antimicrob Agents; 2016 Jan; 47(1):20-7. PubMed ID: 26655034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis.
    Huang HB; Peng JM; Weng L; Wang CY; Jiang W; Du B
    Ann Intensive Care; 2017 Nov; 7(1):114. PubMed ID: 29168046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
    Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
    Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practice Patterns and Outcomes Associated With Procalcitonin Use in Critically Ill Patients With Sepsis.
    Chu DC; Mehta AB; Walkey AJ
    Clin Infect Dis; 2017 Jun; 64(11):1509-1515. PubMed ID: 28329238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.
    Heyland DK; Johnson AP; Reynolds SC; Muscedere J
    Crit Care Med; 2011 Jul; 39(7):1792-9. PubMed ID: 21358400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
    Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
    J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
    Heilmann E; Gregoriano C; Wirz Y; Luyt CE; Wolff M; Chastre J; Tubach F; Christ-Crain M; Bouadma L; Annane D; Damas P; Kristoffersen KB; Oliveira CF; Stolz D; Tamm M; de Jong E; Reinhart K; Shehabi Y; Verduri A; Nobre V; Nijsten M; deLange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Mueller B; Schuetz P
    Clin Chem Lab Med; 2020 Sep; 59(2):441-453. PubMed ID: 32986609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective oropharyngeal decontamination versus selective digestive decontamination in critically ill patients: a meta-analysis of randomized controlled trials.
    Zhao D; Song J; Gao X; Gao F; Wu Y; Lu Y; Hou K
    Drug Des Devel Ther; 2015; 9():3617-24. PubMed ID: 26203227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: a prospective study with propensity score matching analysis.
    Huang TS; Huang SS; Shyu YC; Lee CH; Jwo SC; Chen PJ; Chen HY
    PLoS One; 2014; 9(3):e90539. PubMed ID: 24594916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms.
    Schuetz P; Chiappa V; Briel M; Greenwald JL
    Arch Intern Med; 2011 Aug; 171(15):1322-31. PubMed ID: 21824946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin-guided antibiotic therapy for pediatrics with infective disease: A updated meta-analyses and trial sequential analysis.
    Li P; Liu J; Liu J
    Front Cell Infect Microbiol; 2022; 12():915463. PubMed ID: 36211950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.